Menu
Search
|

Menu

Close
X

Nuvectra Corp NVTR.OQ (NASDAQ Stock Exchange Global Market)

10.20 USD
+0.15 (+1.49%)
As of Feb 23
chart
Previous Close 10.05
Open 10.10
Volume 2,829
3m Avg Volume 23,064
Today’s High 10.25
Today’s Low 10.05
52 Week High 14.55
52 Week Low 5.90
Shares Outstanding (mil) 10.78
Market Capitalization (mil) 110.00
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.50 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY17
20
FY16
13
FY15
5
EPS (USD)
FY17
-3.432
FY16
-3.738
FY15
-2.380
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.62
Price to Sales (TTM)
vs sector
4.58
8.35
Price to Book (MRQ)
vs sector
1.96
5.22
Price to Cash Flow (TTM)
vs sector
--
25.88
Total Debt to Equity (MRQ)
vs sector
47.10
15.84
LT Debt to Equity (MRQ)
vs sector
37.29
12.39
Return on Investment (TTM)
vs sector
-50.64
13.63
Return on Equity (TTM)
vs sector
-62.50
15.39

EXECUTIVE LEADERSHIP

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

5830 Granite Pkwy Ste 1100
PLANO   TX   75024

Phone: +1972.6684107

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).

SPONSORED STORIES